Tenet Healthcare account plan
Comprehensive healthcare services provider
At a glance
Tenet Healthcare runs 51 US hospitals and the USPI ambulatory surgery network, with $21,310 million of net operating revenues in 2025.
Tenet Healthcare is a Dallas-based diversified healthcare services company with two segments: Hospital Operations and Services (51 hospitals in eight states, 135 outpatient facilities and the Conifer revenue cycle business at September 30, 2026) and Ambulatory Care (USPI, with interests in 535 ambulatory surgery centers and 25 surgical hospitals in 37 states). FY2025 net operating revenues were $21,310 million (+3.1%) and net income available to common shareholders $1,407 million ($15.49 per diluted share). Tenet employed about 99,000 people at the end of 2025, plus a Global Business Center in the Philippines with about 5,600 employees. Saumya Sutaria, M.D., is Chairman and CEO.
Business units
Hospital Operations and Services
76% of FY2025 net operating revenues ($16,138 million)Acute care and specialty hospitals in Arizona, California, Florida, Massachusetts, Michigan, South Carolina, Tennessee and Texas, plus urgent care, imaging, off-campus emergency departments, micro-hospitals and employed physicians. Q3 2026 revenues rose 6.1% to $4,260 million with Adjusted EBITDA of $818 million (19.2% margin). Strategy centres on higher-acuity service lines and the specialist network.
Ambulatory Care (USPI)
about 24% of FY2025 net operating revenues ($5,172 million)Ambulatory surgery centers and surgical hospitals, mostly joint ventures with physicians and health systems, in orthopedics, total joint replacement, spine, GI, pain, ENT, ophthalmology and urology. Q3 2026 revenues rose 7.5% to $1,371 million with Adjusted EBITDA of $537 million (39.2% margin).
Conifer Health Solutions
Revenue cycle management and value-based care services for hospitals, health systems and physician practices, reported within Hospital Operations. Wholly owned since CommonSpirit's 23.8% stake was redeemed, it is winding down its CommonSpirit contract, which was substantially complete by October 30, 2026.
Strategic priorities
- Expand ambulatory surgery
- Grow USPI through acquisitions, de novo centers and higher-acuity service lines such as urology, robotics, spine and cardiac; USPI M&A spend is expected to exceed $300 million in 2026.
- Higher-acuity hospital growth
- Invest in the specialist network and higher-demand service lines, including a transfer program bringing high-acuity patients from rural and smaller suburban hospitals.
- Margin through cost work
- Three buckets: traditional efficiencies (contracts, purchased services, supply standardization), clinical operations (length of stay, ED throughput, OR and cath lab use) and technology (automation and AI, including at the Global Business Center).
- AI across care and administration
- AI and generative-AI tools in clinical care coordination, documentation, revenue cycle and administration; agentic patient-outreach tools trialled in ASCs to reduce cancellations.
- Capital returns and structure
- Capital priority order is USPI M&A, hospital higher-acuity growth, share repurchases, then debt; buybacks were $1.615 billion in the first nine months of 2026.
Latest results
In Q3 2026 net operating revenues rose 6.5% to $5,631 million and net income available to common shareholders was $1,000 million ($12.41 per diluted share) versus $342 million a year earlier. Adjusted EBITDA rose 23.3% to $1,355 million (24.1% margin), including a $147 million net favorable impact from the early Conifer contract transition. Nine-month revenues were $16,627 million (+5.3%). Tenet raised its FY2026 outlook to net operating revenues of $22,050-22,450 million and Adjusted EBITDA of $5,050-5,200 million. Lower exchange admissions created an unfavorable payer mix, with charity and uninsured admissions up 26.0%.
Investments and deals
- USPI acquisitions and de novos
- $211 million in the first nine months of 2026 for controlling interests in 13 ASCs, four de novo ASCs opened, and over $100 million invested in development in Q3.
- New hospital capacity
- The 210-bed Nacogdoches Medical Center South Campus opened in August 2026, after the 54-bed Florida Coast Medical Center in September 2025.
- Capital expenditure
- Capex was $1.010 billion in 2025 and is guided to $700-800 million for 2026, covering renovation, surgical expansion, robotics, information systems and new facilities.
- Conifer contract exit with CommonSpirit
- Under the January 27, 2026 agreement CommonSpirit pays $1.900 billion over three years and Conifer redeemed its stake for $540 million.
- Refinancing
- $2.000 billion of 6.250% notes due 2034 issued in September 2026 to redeem the 2027 first-lien notes and part of the 2028 notes.
Challenges and risks
- Exchange coverage losses
- Enhanced ACA premium tax credits expired at the end of 2025; exchange admissions and revenues fell 18% in Q3 2026, with patients converting to uninsured.
- Medicaid policy changes
- The OBBBA brings Medicaid work requirements, caps on state-directed payments and provider-tax limits mostly from 2027, and Tenet cannot yet estimate the impact.
- Labor shortages and unions
- Nurse and clinician shortages, physician recruitment and union activity at 27 hospitals are named risks, alongside California staffing ratios.
- Conifer contributions not recurring
- Conifer transition activities worth $450 million of 2026 Adjusted EBITDA are not expected to recur in 2027.
- California seismic standards
- Hospitals must meet seismic standards by 2030; design work has started and the cost cannot yet be estimated.
What leadership says
“Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management.”
“We remain the preferred acquirer of assets in this space”
“This is not an environment to be pessimistic about with respect to the acute care industry”
“more complex, frankly, requires more behavior change and process redesign”
Where a supplier can help
- AI and automation for cost work
- The technology bucket of the margin plan and AI trials in OR scheduling, charge capture, pre-authorization and patient outreach open doors for healthcare AI and automation vendors.
- Clinical operations improvement
- Length-of-stay, ED throughput and OR and cath lab utilisation work needs process redesign, analytics and scheduling tools.
- ASC build-out and acquisitions
- USPI de novos and acquisitions in robotics, spine, urology and cardiac create demand for surgical equipment, robotics, construction and integration services.
- Supply and purchased-services standardization
- Supply standardization and renegotiation of purchased services, plus tariff and supply-chain cost risks, favour suppliers offering lower total cost.
- Uninsured and payer-mix management
- Rising uninsured admissions after exchange coverage losses point to eligibility, financial-counselling and revenue-cycle tools.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Tenet Healthcare?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Form 10-K for the fiscal year ended December 31, 2025
- Tenet Healthcare is a Dallas-based diversified healthcare services company with two reporting segments: Hospital Operations and Services (50 acute care and specialty hospitals in eight states, 132 outpatient facilities, employed physicians, and the Conifer Health Solutions revenue cycle business) and Ambulatory Care (USPI: interests in 533 ASCs and 26 surgical hospitals in 37 states).
- FY2025 net operating revenues were $21,310 million (+3.1%): Hospital Operations $16,138 million (76% of the total) and Ambulatory Care $5,172 million (+14.1%). Net income available to common shareholders was $1,407 million ($15.49 per diluted share) versus $3,200 million in 2024, when hospital sales produced $2.916 billion of gains.
- Segment Adjusted EBITDA: Hospital Operations $2,540 million, Ambulatory Care $2,026 million, total $4,566 million. Ambulatory Care's operating margin was 34.4%, against 10.7% for Hospital Operations.
- Strategy: grow USPI through acquisitions, de novo centers and higher-acuity service lines. In 2025 it acquired controlling interests in 27 ASCs and one surgical hospital and opened six de novo ASCs. Hospitals focus on higher-demand service lines and the specialist network; the 54-bed Florida Coast Medical Center opened in September 2025.
- Conifer: on January 27, 2026 Tenet agreed with CommonSpirit Health to end Conifer's master services agreement for certain CommonSpirit facilities effective December 31, 2026. CommonSpirit pays $1.900 billion in annual installments over three years, and Conifer redeems CommonSpirit's 23.8% stake for $540 million.
- About 99,000 employees (Hospital Operations 75,000, Ambulatory Care 24,000), plus about 5,600 at the Global Business Center in the Philippines. About 20% of Hospital Operations employees are unionized.
- Capital: capex was $1.010 billion in 2025 and is guided to about $700-800 million for 2026. Share buybacks were $1.386 billion in 2025, with $1.490 billion left on the authorization. Debt was refinanced with $1.500 billion of 2032 first-lien notes and $750 million of 2033 senior notes, and all long-term debt carries fixed rates.
- Main risks: the OBBBA (Medicaid work requirements, caps on state-directed payments and provider taxes, mostly from 2027), the end of enhanced ACA premium tax credits after 2025, managed care contracting (69.5% of hospital net patient service revenues), labor shortages and cybersecurity.
- Uses AI and generative-AI tools in clinical care coordination, medical documentation, revenue cycle management and administrative services.
- Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 net operating revenues were $5,631 million (+6.5%): Hospital Operations $4,260 million (+6.1%), Ambulatory Care $1,371 million (+7.5%). Nine-month revenues were $16,627 million (+5.3%).
- The Conifer/CommonSpirit agreements are being wound down early. The transition will be substantially complete by October 30, 2026 rather than December 31, 2026, so Q3 included catch-up adjustments of $233 million to revenue from contract termination and $97 million to net operating revenues. Nine-month revenue from contract termination was $1,472 million.
- Operating income was $1,750 million in Q3 2026 against $889 million a year earlier. Salaries, wages and benefits fell 1.4% and dropped to 38.6% of revenues from 41.7%.
- Hospital volumes: admissions +3.3% and ED visits +4.6%. Charity and uninsured admissions rose 26.0%, reflecting lower exchange coverage and an unfavorable payer mix.
- Footprint at September 30, 2026: 51 hospitals in eight states, 135 outpatient facilities, and USPI interests in 535 ASCs (406 consolidated) and 25 surgical hospitals in 37 states. Nacogdoches Medical Center South Campus (210 beds) opened in August 2026.
- USPI spent $211 million in nine months on controlling interests in 13 ASCs, opened four de novo ASCs and closed 17 ASCs and one surgical hospital.
- Balance sheet: $2.000 billion of 6.250% notes due 2034 refinanced the $1.500 billion 2027 first-lien notes and $500 million of the 2028 notes. Cash was $2.674 billion. Q3 buybacks were $255 million.
- Medicaid DSH and supplemental revenues were $356 million in Q3 and $1.107 billion in nine months. Tenet says it cannot yet estimate the OBBBA's impact.
- Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook (earnings release, Exhibit 99.1)
- Q3 2026: net operating revenues $5,631 million; net income available to common shareholders $1.000 billion ($12.41 per diluted share) versus $342 million ($3.86); adjusted diluted EPS $6.64, up 79.5% from $3.70.
- Consolidated Adjusted EBITDA was $1.355 billion (+23.3%), a 24.1% margin. This includes a $147 million net favorable impact from the early transition of the CommonSpirit revenue cycle contracts: a $97 million revenue timing catch-up plus about $50 million of transition benefits.
- Ambulatory (USPI): Adjusted EBITDA $537 million (+9.1%), margin 39.2%; same-facility system-wide net patient service revenues +4.5% (cases -1.5%, revenue per case +6.1%).
- Hospital: Adjusted EBITDA $818 million versus $607 million, margin 19.2% versus 15.1%; same-hospital adjusted admissions +3.2%. Payer mix was unfavorable because of lower exchange admissions.
- FY2026 outlook raised: Adjusted EBITDA $5.05-5.20 billion (+$195 million at the midpoint), net operating revenues $22,050-22,450 million, adjusted free cash flow $2.825-3.125 billion, capex $700-800 million.
- Buybacks: 7.99 million shares for $1.615 billion in nine months. Net debt to Adjusted EBITDA was 2.11x versus 2.25x at end-2025.
- Saum Sutaria, Chairman and CEO, credited "sustained strength in same-store revenue growth and effective expense management".
- Tenet Healthcare Q3 2026 earnings call transcript
- CEO Saumya Sutaria: excluding $147 million of one-time Conifer contract-transition items, "the core business continued its strong growth trajectory". Hospital Adjusted EBITDA grew 11% on that basis.
- FY2026 Adjusted EBITDA guidance raised by $195 million (4% at the midpoint) to $5.05-5.2 billion. Over 40% of the year's total guidance increase comes from fundamental outperformance.
- Early 2027 view: excluding Conifer transition activities (expected at $450 million of 2026 Adjusted EBITDA, not recurring), Tenet expects overall Adjusted EBITDA growth in 2027, under current regulatory frameworks.
- USPI: Adjusted EBITDA $537 million (+9%); same-facility revenues +4.5%; total joint replacements in ASCs +12.8% same-store. Over $100 million invested in development in Q3; "We remain the preferred acquirer of assets in this space."
- Exchange admissions and revenues fell 18% year on year and are about 5.5% of revenues. About 60% of admissions are from Medicaid expansion states. Commercial renewals are running at 3% to 5%, with over 90% of next year already contracted.
- Capital priorities: USPI M&A, hospital higher-acuity growth, buybacks ($1.615 billion year to date), then debt. Leverage is 2.11x EBITDA.
- Growth areas beyond orthopedics: urology, general surgery, advanced robotics, spine and new cardiac centers. Tenet is also trying AI and agentic tools for OR scheduling, patient outreach and pre-authorization.
- Tenet Healthcare Q2 2026 earnings call transcript
- Q2 2026: net operating revenues $5.6 billion; Adjusted EBITDA $1.304 billion (+16.3%), margin 23.2%; adjusted EPS $6.12 (+52%).
- FY2026 Adjusted EBITDA guidance raised by $295 million (6% at the midpoint) to $4.83-5.03 billion: USPI $2.16-2.22 billion, hospitals $2.67-2.81 billion. USPI M&A spend is now expected to exceed $300 million in 2026.
- USPI: Adjusted EBITDA $542 million (+9%); same-facility revenues +5%; total joint replacement volume +10%. Sutaria: "USPI is the premier ambulatory surgical asset in the space."
- Hospitals: Adjusted EBITDA $762 million (+22%), margin 18%. Exchange revenues fell 17% (about $65 million of revenue headwind), with the hardest hit in Florida, Arizona, Michigan, South Carolina and Texas.
- Margin plan in three buckets: classic efficiencies (contracts, purchased services, supply standardization), clinical operations (length of stay, ED throughput, OR and cath lab use), and technology (automation and AI, with the Global Business Center).
- Capital: $1.36 billion of buybacks in H1 and a $2 billion increase to the repurchase authorization. Tenet is more cautious on large hospital builds, recently one to two per year.
- Sutaria on demand: "this is not an environment to be pessimistic about with respect to the acute care industry". He sees no consumer pullback.
Questions about Tenet Healthcare
What does Tenet Healthcare do?
Tenet operates acute care and specialty hospitals and outpatient facilities in eight states, the USPI network of ambulatory surgery centers and surgical hospitals in 37 states, and Conifer revenue cycle services.
What is Tenet Healthcare's revenue?
Net operating revenues were $21,310 million in FY2025. For FY2026 Tenet guides to $22,050-22,450 million after Q3 2026 revenues of $5,631 million.
How many employees does Tenet Healthcare have?
About 99,000 at December 31, 2025, about 75,000 in Hospital Operations and 24,000 in Ambulatory Care, plus about 5,600 at its Global Business Center in the Philippines.
Who leads Tenet Healthcare?
Saumya Sutaria, M.D., is Chairman and CEO, and Sun Park is EVP and CFO.
What is Tenet's strategy?
Expand USPI ambulatory surgery, grow higher-acuity hospital services, improve margins through efficiencies, clinical operations and AI, and return capital through buybacks.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)